«My point is that future emissions will not just happen, they will be choosen (to some extent)...» Well, I assume you probably already know this, but the IPCC TAR scenarios explicitly EXCLUDE any reductions emissions that would occur as
a result of any future government actions.
Not exact matches
Important factors that could cause actual
results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability
of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost
of accommodating, announced increases in the build rates
of certain aircraft; 6) the effect on aircraft demand and build rates
of changing customer preferences for business aircraft, including the effect
of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a
result of global economic uncertainty or otherwise; 8) the effect
of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution
of key milestones such as the receipt
of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation
of our announced acquisition
of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate,
future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability
of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk
of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production
of aircraft
resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts
of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak
of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact
of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition
of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect
of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect
of changes in tax law, such as the effect
of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations
of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect
of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability
of raw materials and purchased components; 23) our ability to recruit and retain a critical mass
of highly - skilled employees and our relationships with the unions representing many
of our employees; 24) spending by the U.S. and other
governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment
of interest on, and principal
of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness
of any interest rate hedging programs; 28) the effectiveness
of our internal control over financial reporting; 29) the outcome or impact
of ongoing or
future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition
of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a
result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks
of doing business internationally, including fluctuations in foreign current exchange rates, impositions
of tariffs or embargoes, compliance with foreign laws, and domestic and foreign
government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial
results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount
of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and
future negotiations with commercial and
government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability
of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction
of generic versions
of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other
government action that could have the effect
of lowering prices or reducing the number
of insured patients; the possibility
of unfavorable
results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels
of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits
of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages
of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development
of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate
of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's
future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
The increase in program expenses was primarily the
result of the inclusion in the August 2012 financial
results of «an updated accrual estimate for employee and veterans»
future employee benefits based on accrual valuations prepared for the
Government's 2011 - 12 financial statements».
These statements may involve a number
of risks, uncertainties and other factors that could cause actual
results to differ materially, including the performance
of financial markets, the investment performance
of NexPoint Advisors, L.P.'s or Highland Capital Management L.P.'s sponsored investment products, general economic conditions,
future acquisitions, competitive conditions and
government regulations, including changes in tax laws.
The
result will be the same as the US, the too big to fail banks will be gifted huge swags
of Government printed money,
Government revenue will collapse and they will then print 50 %
of their budget into the foreseeable
future.
Certain statements in this press release regarding the Company's expected
future shipment volumes, gross margins, and its ability to receive the required
government approvals for the sale
of six solar power projects in California, are forward - looking statements that involve a number
of risks and uncertainties that could cause actual
results to differ materially.
We expect that additional U.S. federal healthcare reform measures will be adopted in the
future, any
of which could limit the amounts that the U.S. federal
government will pay for healthcare products and services, which could
result in reduced demand for our product candidates or additional pricing pressures.
These risks, delays, and uncertainties include, but are not limited to: risks associated with the uncertainty
of future financial
results, our reliance on our sole supplier, the limited diversification
of our product offerings, additional financing requirements, development
of new products,
government approval processes, the impact
of competitive products or pricing, technological changes, the effect
of economic conditions and other uncertainties detailed in the Company's filings with the Securities and Exchange Commission.
The «left wing» refuses to acknowledge legitimate flaws in the regs and accuses the right
of politicizing our children's
future and always fighting against anything the Obama administration puts forward, and the «right wing» isn't recognizing any
of the improvements that were made as a
result of the regs and blaming the
government for over regulating and not giving the administration an ounce
of credit for at least taking on an overhaul
of a system that hadn't seen significant reform in 20 years.
The vote in 2007 was itself an FPTP vote on the
future of the Lords, rather than a preferential vote, and I remember it being couched in no uncertain terms at the time as 100 % being the obstreperous option that would
result in Lords reform progressing the slowest; indeed, despite wide - ranging support in the Commons for 100 % elected Lords, the Labour
government indeed made no progress whatsoever on such legislation.
As a
result of the implementation
of the Free SHS policy, the President stated that his
Government is laying a strong foundation for an educated and skilled workforce
of the
future, adding that «we are investing in our
future scientists, engineers, modern farmers, innovators, entrepreneurs, and transformation agents!»
«This is an example
of government working at its best and this decision will
result in a tremendous benefit to our farm communities in the
future.»
Participants took part in a real - time electronic poll which explored their views on a series
of issues relating to their profession: Among the
results were: over three quarters
of BME teachers considered themselves to be ambitious, yet stated they are being held back by racial discrimination, and the attitude
of senior colleagues; nearly two - thirds (62 %)
of BME teachers felt their school or college was not seriously committed to addressing their professional development needs and aspirations; 63 %
of BME teachers said their employers were not committed to ensuring their mental and physical wellbeing at work, with workload cited as the single most negative factor impacting on their wellbeing; the vast majority
of BME teachers felt the
Government does not respect and value teachers and does not understand the day to day realities
of teaching (99 %); three quarters
of BME teachers said they were not confident that their headteacher will make professional and fair decisions regarding their
future pay.
Their concerns date back to those five febrile days in May after the cliffhanger poll
result left the
future of the country in the balance as Cameron, Clegg and Labour negotiators bartered behind closed doors over who would form the next
government.
«That this House opposes the
Government's plans to impose a polyclinic, or GP - led health centre, in every primary care trust; regrets that this could
result in the closure
of up to 1,700 GP surgeries; is concerned that the imposition
of polyclinics against the will
of patients and GPs could be detrimental to standards
of care, particularly for the elderly and vulnerable, by breaking the vital GP / patient link; further regrets that these plans are being imposed without consultation; is alarmed at the prospective loss
of patient access to local GP services at a time when care closer to home should be strengthened; believes that the
Government's plans would jeopardise the independence and commissioning capability
of general practice in the
future; supports the strengthening
of access to diagnostic and therapeutic services without undermining the structure
of GP services; and calls on the
Government to reconsider its plans for polyclinics.
This he said was in spite
of the fact their decision to shut down the institution had
resulted in increase in violent crimes on Ayingba and its environs, adding that «as a responsible
government who has high regard for education as the pillar
of the
future of the state, we can not afford to fold our hands and watch the
future of our youths mortgaged».
If at a General Election the national figures were Conservative 44 % Labour 26 % Liberal Democrat 17 % then I rather suspect that actually the majority would be
of over 150 - the Liberal Democrats might manage to hold onto as many as 40 seats, Labour would go way down though below 200 seats, the Conservatives would probably break through 400 seats, it does depend a lot on tactical voting, however the likliehood
of a such a
result in the next 10 years is virtually nil, in the longer term I would say it was quite probable at some stage in the
future once the Labour
government finally collapses.
Compare the
results of this scheme to the previous
government's
Future Jobs Fund (FJF), which Duncan Smith dismissed as a waste
of money.
No one is more concerned than the Japanese, who are surrounded by seas; about 73 %
of Japan is forested, mountainous, and unsuitable for agricultural, industrial, or residential use, as a
result, the habitable zones are mainly located in or near coastal areas, so much so that, there are growing concerns in Japan
of the impact
of climate change on their coastal surroundings, prompting the Japanese
government to set up an Intergovernmental Panel on Climate Change (IPCC) to undertake a study on climate change, to provide
future projections
of coastal erosion based on representative concentration pathway (RCP) scenarios.
These risks and uncertainties include, among others, those relating to our ability to obtain financing and to form collaborative relationships, uncertainty regarding potential
future deterioration in the market for auction rate securities which could
result in additional permanent impairment charges, our ability to develop and market diagnostic products, the level
of third party reimbursement for our products, risks related to preclinical and clinical development
of pharmaceutical products, including the identification
of compounds and the completion
of clinical trials, the effect
of government regulation and the regulatory approval processes, market acceptance, our ability to obtain and protect intellectual property rights for our products, dependence on collaborative relationships, the effect
of competitive products, industry trends and other risks identified in deCODE's filings with the Securities and Exchange Commission, including, without limitation, the risk factors identified in our most recent Annual Report on Form 10 - K and any updates to those risk factors filed from time to time in our Quarterly Reports on Form 10 - Q or Current Reports on Form 8 - K.
Climate change scenarios are based on projections
of future greenhouse gas (particularly carbon dioxide) emissions and
resulting atmospheric concentrations given various plausible but imagined combinations
of how
governments, societies, economies, and technologies will change in the
future.
As a
result, European women aren't that interested in meeting rich and powerful men — they are not worried about the
future of their children because everyone is looked after very well by the
government anyway.
X-Men's action takes place in the near
future, when the United States Senate is debating a bill that will require all mutants (human beings who possess special powers as a
result of DNA mutations) to register with the
government.
Since the election
of the coalition
government in 2010, the school construction programme has experienced a major change
of direction,
resulting in general uncertainty regarding the
future of acoustic design and legislation for schools, and there is a risk
of the importance
of acoustic design in schools being undermined.
To avoid the catastrophic
future that is pronounced for the humanity
of the
resulting economic and environmental threats, it is essential to have the commitment
of governments, public and private productive sector and individuals with the model
of sustainable development.
Achieving this more efficient and effective system will be crucial if the
government is to meet the challenges
of the
future — not least in the face
of a possible recession following the referendum
result.
The IFS has also warned that the date by which all schools would reach their formula level
of funding could differ significantly as a
result of the spending decisions
of a
future government.
Disagreements between
governments on the
future of the EU and economic policies will most probably
result in a weakening
of the euro against the Japenese yen.
NCSE isn't composed
of scientists or science teachers; it's an activist group devoted, in part, to expounding global warming alarmists» dogma: Humans are causing climate change; the
results will be catastrophic; and
governments must force people to use less energy and live simpler to prevent
future disasters.
«Up to two - and - a-half years ago industry believed that, after the Kyoto Protocol, national
governments would agree on a new international agreement that (would) commit both developed and developing countries to reducing their greenhouse gas emissions, and that, as a
result, they would force the industry to proceed with CCS,» said Stefan Bachu
of Alberta's provincially funded research organization, Alberta Innovates Technology
Futures (AITF).
They evaluate the supercomputer model
results and develop a coordinated assessment
of future global warming under the auspices
of the United Nations, including extensive review by both individual scientists and
governments.
-- which can be found here, draws upon the
results of a series
of UK
Government - sponsored studies which employed the IPCC's emissions scenarios to project
future climate change between 1990 and 2100 and its global impacts on various climate - sensitive determinants
of human and environmental well - being (such as malaria, hunger, water shortage, coastal flooding, and habitat loss).
Facebook and the UK
government have been, under warrant, searching the CA premises, and the end
result so far is that people's privacy and the
future of data sharing on Facebook is in doubt.
If this traditional position were followed, then it would be free to any present or
future government to trigger the proceedings for a withdrawal in accordance with Article 50, or indeed to ignore the
result of the referendum and choose not to withdraw.
Rick Georges
of Future Lawyer says that Google shouldn't be a bit surprised that it's being accused
of acting unlawfully in China, for once it made a deal to do business there and work with censorship
of its search
results, it should expect the Chinese
government to chip away further at the company.
Non-lawyers at claims management firms could be left in charge
of running complex personal injury cases in
future as a
result of government reforms, legal campaigners have claimed.
No nation can afford to be neutral about the substantial impact that such dislocation imposes on the well - being
of future generations and the
resulting effects
of spurring the growth
of government and slowing the economy.
The combined practices
of the Northern Territory
Government in regard to the right to negotiate appear to
result from a policy decision by the Northern Territory
Government to process the mining tenement backlog is dealt with as swiftly as possible by forcing as many tenement applications through the NTA
future act processes as is possible in a short period
of time.
The industry welcomed many
of those changes and believes that policymakers can take further steps that would stabilize FHA single family programs, starting with a rigorous look at the data driving the actuarial
results and an open, robust discussion over the
future of the
government's role in housing finance.»